News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,904 Results
Type
Article (13750)
Company Profile (101)
Press Release (251053)
Section
Business (88033)
Career Advice (465)
Deals (15342)
Drug Delivery (67)
Drug Development (36595)
Employer Resources (49)
FDA (6287)
Job Trends (6195)
News (150193)
Policy (14025)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (30)
Alliances (23211)
ALS (36)
Alzheimer's disease (382)
Antibody-drug conjugate (ADC) (35)
Approvals (6317)
Artificial intelligence (100)
Autoimmune disease (7)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (54)
Biotechnology (40)
Bladder cancer (18)
Brain cancer (15)
Breast cancer (74)
Cancer (566)
Cardiovascular disease (66)
Career advice (407)
Career pathing (11)
CAR-T (20)
Cell therapy (80)
Cervical cancer (4)
Clinical research (30836)
Collaboration (315)
Compensation (131)
Complete response letters (16)
COVID-19 (757)
CRISPR (19)
C-suite (109)
Cystic fibrosis (35)
Data (568)
Denatured (15)
Depression (9)
Diabetes (75)
Diagnostics (1312)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (53)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32004)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37355)
Executive appointments (346)
FDA (6661)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (201)
Gene editing (37)
Generative AI (8)
Gene therapy (97)
GLP-1 (335)
Government (1285)
Grass and pollen (2)
Guidances (15)
Healthcare (3561)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (32)
Indications (12)
Infectious disease (788)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (43)
Interviews (59)
IPO (5874)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (9)
Layoffs (176)
Leadership (3)
Legal (3429)
Liver cancer (19)
Lung cancer (75)
Lymphoma (50)
Machine learning (1)
Management (16)
Manufacturing (138)
MASH (29)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (9649)
Metabolic disorders (239)
Multiple sclerosis (17)
NASH (14)
Neurodegenerative disease (21)
Neuropsychiatric disorders (6)
Neuroscience (542)
NextGen: Class of 2025 (1585)
Non-profit (593)
Northern California (657)
Now hiring (7)
Obesity (137)
Opinion (118)
Ovarian cancer (20)
Pain (49)
Pancreatic cancer (13)
Parkinson's disease (41)
Partnered (5)
Patents (100)
Patient recruitment (28)
Peanut (9)
People (28835)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8026)
Phase II (13047)
Phase III (11706)
Pipeline (355)
Podcasts (46)
Policy (58)
Postmarket research (1401)
Preclinical (3205)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (119)
Rare diseases (156)
Real estate (2633)
Recruiting (17)
Regulatory (10061)
Reports (14)
Research institute (563)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (32)
Series A (35)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (668)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1627)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6667)
Vaccines (149)
Venture capitalists (13)
Webinars (10)
Weight loss (93)
Women's health (8)
Worklife (3)
Date
Today (47)
Last 7 days (187)
Last 30 days (1015)
Last 365 days (12121)
2025 (2763)
2024 (12500)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14886)
2018 (11713)
2017 (13889)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (51)
Arkansas (3)
Asia (20065)
Australia (2602)
California (1590)
Canada (859)
China (216)
Colorado (64)
Connecticut (65)
Delaware (51)
Europe (39308)
Florida (295)
Georgia (34)
Idaho (9)
Illinois (179)
India (13)
Indiana (126)
Iowa (1)
Japan (80)
Kansas (54)
Kentucky (12)
Maine (2)
Maryland (243)
Massachusetts (1368)
Michigan (27)
Minnesota (88)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (693)
New Mexico (7)
New York (463)
North Carolina (372)
North Dakota (2)
Northern California (657)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (400)
Puerto Rico (8)
Rhode Island (6)
South America (501)
South Carolina (2)
Southern California (668)
Tennessee (34)
Texas (213)
Utah (33)
Virginia (69)
Washington D.C. (29)
Washington State (109)
Wisconsin (14)
264,904 Results for "cannabics pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Business
Radiation Oncology Expert Joins Cannabics Pharmaceuticals’ Board of Advisors
Cannabics Pharmaceuticals Inc. announced today that Dr. Yonina Tova (MD), internationally recognized Radiation Oncologist has joined the company’s Board of Advisors.
October 25, 2021
·
3 min read
Business
Cannabics Pharmaceuticals Appoints a Second Independent Board Member
Cannabics Pharmaceuticals Inc. announced today that it has appointed Dr. Gil Feiler to its Board of Directors as an Independent Director.
July 20, 2021
·
5 min read
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Business
Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member
Cannabics Pharmaceuticals Inc. announced today that it has appointed Dr. Inbar Maymon-Pomeranchik to its Board of Directors as an Independent Director.
July 7, 2021
·
4 min read
BioCapital
Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer
Cannabics Pharmaceuticals Inc. announced today that it has filed 2 new Provisional Patent applications on Compositions and Methods for treating cancer, including colorectal cancer and early intervention therapy for colorectal cancer patients.
October 18, 2021
·
3 min read
BioCapital
Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program
Cannabics Pharmaceuticals Inc., a global leader in the development of cancer related cannabinoid-based medicine, announced the launching of a new research program for the development of a Breast Cancer antitumor targeting medicine.
June 3, 2021
·
3 min read
BioCapital
Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program using Psylocibin and Psilocin.
April 20, 2021
·
3 min read
BioCapital
Cannabics Pharmaceuticals’ Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice
Cannabics Pharmaceuticals Inc. released today the interim results of its second in-vivo POC study evaluating the efficacy of company’s proprietary drug candidate RCC-33 for the treatment of colorectal cancer on mice.
June 28, 2021
·
4 min read
Press Releases
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
March 17, 2025
·
4 min read
1 of 26,491
Next
